Article Dec 20, 2024 Advancing EoE Histopathology With Emerging AI Solutions From Alimentiv Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or… Read Now
Interview Dec 4, 2024 Spatial Transcriptomics Expertise: An Interview With Dr. Wendy Teft Wendy Teft, PhD, Vice President of Precision Medicine and Head of AcelaBio AcelaBio, Alimentiv’s state-of-the-art specialty laboratory, specializes in delivering high-quality histopathology and precision medicine… Read Now
Article Aug 2, 2023 Why aren’t more Clinical Trials using Adaptive Designs? If adaptive designs can bring strong advantages to clinical trials, then why does their adoption remain low? Clinical trials typically follow a fixed design, where… Read Now
Article Jun 30, 2023 What is the Difference between Biostatistics and Statistics? In the life sciences field, there are two terms that often come up when describing the analysis of data; biostatistics and statistics, which are often… Read Now
News Jun 26, 2023 Alimentiv Inc. launches Alimentiv Statistics London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the… Read Now
Article Apr 18, 2023 Pharmacokinetics vs Pharmacodynamics: Understanding their role in Drug Discovery Pharmacokinetics vs Pharmacodynamics: each play a crucial role in the drug discovery process by providing insight into how drugs work in the body and how… Read Now
Article Mar 21, 2023 A Practical Look at Sample Size Re-Estimation of the Promising Zone Design The randomized controlled clinical trial (RCT) with a fixed design has become a gold standard for evaluating drug safety and efficacy since its debut. However,… Read Now
Article Jan 20, 2023 The Ultimate Glossary of Clinical Study Design & Statistical Analysis Terms At Alimentiv, we place a high priority on educating our audience and clients about clinical statistical analysis and trial design. As such, we decided it was… Read Now
